Browse our extensive catalog of high-quality chemicals for research and development.
| Product Name | Description | CAS Number | Molecular Formula | Molecular Weight | Description |
|---|---|---|---|---|---|
| Dehydroxy Bromocelecoxib | 4-[5-[4-(Bromomethyl)phenyl]-3-(trifluoromethyl)-1H-pyrazol-1-yl]-benzenesulfonamide | 170570-75-9 | C17H13BrF3N3O2S | 460.27 | 4-[5-[4-(Bromomethyl)phenyl]-3-(trifluoromethyl)-1H-pyrazol-1-yl]-benzenesulfonamide
|
| 5-Dehydroepisterol | Ergosta-5,7,24(28)-trien-3beta-ol; Campesta-7,24(28)-dien-3beta-ol; | 23582-83-4 | C28H44O | 396.65 | Ergosta-5,7,24(28)-trien-3beta-ol; Campesta-7,24(28)-dien-3beta-ol;
|
| 3-Dehydroxy 2,3-Dehydro Atorvastatin Lactone | 1-[2-[(2S)-3,6-Dihydro-6-oxo-2H-pyran-2-yl]ethyl]-5-(4-fluorophenyl)-2-(1-methylethyl)-N,4-diphenyl-1H-pyrrole-3-carboxamide | 442851-50-5 | C33H31FN2O3 | 522.61 | 1-[2-[(2S)-3,6-Dihydro-6-oxo-2H-pyran-2-yl]ethyl]-5-(4-fluorophenyl)-2-(1-methylethyl)-N,4-diphenyl-1H-pyrrole-3-carboxamide
|
| 2,3-Dehydroxy Atorvastatin Sodium Salt (E/Z Mixture) | (5S)-7-[2-(4-Fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]-5-hydroxy-2-heptenoic Acid Sodium Salt; | NA | C33H32FN2NaO4 | 562.61 | (5S)-7-[2-(4-Fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]-5-hydroxy-2-heptenoic Acid Sodium Salt;
|
| 21-Dehydro Betamethasone 17-Valerate | 9 alpha-Fluoro-11 beta-hydroxy-16 beta-methyl-17 alpha-valeryloxy-3,20-dioxopregna-1,4-dien-21-al; | NA | C27H35FO6 | 474.56 | 9 alpha-Fluoro-11 beta-hydroxy-16 beta-methyl-17 alpha-valeryloxy-3,20-dioxopregna-1,4-dien-21-al;
|
| 21-Dehydro Betamethasone | (11 beta,16 beta)-9-Fluoro-11,17-dihydroxy-16-methyl-3,20-dioxopregna-1,4-dien-21-al; | 61558-12-1 | C22H27FO5 | 390.45 | (11 beta,16 beta)-9-Fluoro-11,17-dihydroxy-16-methyl-3,20-dioxopregna-1,4-dien-21-al;
|
| Dehydro Barnidipine | Methyl 2,6-Dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic Acid (3S)-1-(Phenylmethyl)-3-pyrrolidinyl Ester; | 172331-68-9 | C27H27N3O6 | 489.52 | Methyl 2,6-Dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic Acid (3S)-1-(Phenylmethyl)-3-pyrrolidinyl Ester;
|
| 21-Dehydro Betamethasone 17-Propionate | (11 beta,16 beta)- 9-Fluoro-11-hydroxy-16-methyl-3,20-dioxo-17-(1-oxopropoxy)pregna-1,4-dien-21-al; | NA | C25H31FO3 | 446.51 | (11 beta,16 beta)- 9-Fluoro-11-hydroxy-16-methyl-3,20-dioxo-17-(1-oxopropoxy)pregna-1,4-dien-21-al;
|
| (+)-Lycopsamine N-Oxide | (2S)-2-Hydroxy-2-[(1S)-1-hydroxyethyl]-3-methylbutanoic Acid [(1R,7aR)-2,3,5,7a-tetrahydro-1-hydroxy-4-oxido-1H-pyrrolizin-7-yl]methyl Ester; [1R-[1alpha,7(2S*,3S*),7abeta]]-2,3-dihydroxy-2-(1-methylethyl)butanoic Acid (2,3,5,7a-tetrahydro-1-hydroxy-1H-pyrrolizin-7-yl)methyl Ester N-Oxide; | 95462-15-0 | C15H25NO6 | 315.36 | (2S)-2-Hydroxy-2-[(1S)-1-hydroxyethyl]-3-methylbutanoic Acid [(1R,7aR)-2,3,5,7a-tetrahydro-1-hydroxy-4-oxido-1H-pyrrolizin-7-yl]methyl Ester; [1R-[1a... |
| 14,15-Dehydro Budesonide | (11 b,16 alpha)-16,17-[Butylidenebis(oxy)beta]-11,21-dihydroxypregna-1,4,14-triene-3,20-dione; Budesonide Impurity E (EP); Budesonide EP Impurity E | 131918-64-4 | C25H32O6 | 428.52 | (11 b,16 alpha)-16,17-[Butylidenebis(oxy)beta]-11,21-dihydroxypregna-1,4,14-triene-3,20-dione; Budesonide Impurity E (EP); Budesonide EP Impurity E
... |
Page 1840 of 10017